导航癌症性心脏病和严重冠状动脉疾病的复杂性:多学科合作的案例
1Cardiology, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, USA.
Cureus
|February 2, 2026
概括
这份病例报告详细介绍了一名患有严重冠状动脉疾病和由转移性神经内分泌瘤引起的癌症性心脏病的患者. 它强调了诊断方面的挑战,以及对复杂心脏病的多学科护理的需要.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
背景情况:
- 一名71岁的男性出现了表明心力衰竭的症状.
- 该患者有转移性神经内分泌瘤 (NET) 的病史.
- 同时存在的严重冠状动脉疾病 (CAD) 和癌性心脏病 (CHD) 呈现出复杂的临床情景.
研究的目的:
- 报告一个具有挑战性的同时出现CAD和CHD的病例.
- 为了说明NET相关心脏并发症的诊断方式.
- 强调多学科方法在管理复杂的心脏病理方面的重要性.
主要方法:
- 临床表现和症状分析.
- 诊断工作包括冠状动脉评分.
- 声心成像用于心脏评估.
- 用于NET分期的正子发射断层扫描/计算机断层扫描 (PET/CT).
主要成果:
- 升高的冠状动脉分数表明严重的冠状动脉硬化.
- 心声图的发现与典型的心脏病的右侧心脏参与相一致.
- PET/CT证实转移性NET是心脏病的根本原因.
结论:
- 慢性肺炎和慢性肺炎的共存带来了重大的诊断和管理挑战.
- 综合诊断方法对于识别NET患者心脏参与至关重要.
- 多学科团队合作对于优化复杂心血管和瘤病例患者的治疗结果至关重要.
相关概念视频
Coronary Artery Disease I: Introduction
1.1K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology
451
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
451
Coronary Artery Disease V: Interprofessional Care
269
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
269
Coronary Artery Disease III: Clinical Manifestations
373
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
373
Coronary Artery Disease IV: Preventive Measures
693
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
693
Peripheral Artery Disease I: Introduction
378
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
378


